Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design.
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design. J Clin Cell Immunol. 2015 Aug; 6(4).
View in:
PubMed
authors with profiles
Azizul Haque